These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Kwon Y, Ro J, Kang HS, Kim SK, Hong EK, Khang SK, Gong G, Ro JY. Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771 [Abstract] [Full Text] [Related]
4. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN, Cox CE, Reintgen DS. Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010 [Abstract] [Full Text] [Related]
8. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group. Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163 [Abstract] [Full Text] [Related]
12. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer. Fujii T, Yajima R, Tatsuki H, Kuwano H. Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160 [Abstract] [Full Text] [Related]
13. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE. Am J Surg; 2002 Oct; 184(4):302-6. PubMed ID: 12383888 [Abstract] [Full Text] [Related]
14. Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases. Mamtani A, Patil S, Van Zee KJ, Cody HS, Pilewskie M, Barrio AV, Heerdt AS, Morrow M. Ann Surg Oncol; 2016 Oct; 23(11):3481-3486. PubMed ID: 27169771 [Abstract] [Full Text] [Related]
15. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact. Dabbs DJ, Fung M, Johnson R. Breast J; 2004 Oct; 10(3):190-4. PubMed ID: 15125743 [Abstract] [Full Text] [Related]
16. Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer. Dong LF, Xu SY, Long JP, Wan F, Chen YD. J Int Med Res; 2018 Feb; 46(2):828-835. PubMed ID: 29441833 [Abstract] [Full Text] [Related]
17. Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node. Meattini I, Saieva C, Bertocci S, Francolini G, Zei G, De Luca Cardillo C, Scotti V, Greto D, Bonomo P, Orzalesi L, Bianchi S, Livi L. Tumori; 2015 Feb; 101(1):78-83. PubMed ID: 25702658 [Abstract] [Full Text] [Related]
18. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy. Barron AU, Hoskin TL, Boughey JC. Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095 [Abstract] [Full Text] [Related]
19. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms? Biolchini F, Vicentini M, Di Felice E, Giovanardi F, Antonio L, Giorgi Rossi P, Annessi V. Tumori; 2015 Oct; 101(3):298-305. PubMed ID: 25838248 [Abstract] [Full Text] [Related]
20. Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node. Eiró N, González LO, Atienza S, González-Quintana JM, Beridze N, Fernandez-Garcia B, Pérez-Fernández R, García-Caballero T, Schneider J, Vizoso FJ. Eur J Cancer; 2013 Mar; 49(5):1009-17. PubMed ID: 23063352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]